Entries by oslocancer

Our international Work

Oslo Cancer Cluster aims to enhance the visibility of oncology innovation made in Norway by being a significant partner for international clusters, global biopharma companies and academic centres. – Our goal is to support our members in their effort to attract international partners, investments and successful academia-industry collaborations, says International Advisor Jutta Heix. Heix is […]

New Board Members

Our newest board members are officially introduced!  On the 24th of May in 2017, the general assembly meeting took place and fatefully decided Oslo Cancer Cluster’s newest board members. These members, despite having some big seats to fill, will take on a respectful duty belonging to the board: where professionals in the field function as the […]

How our genes will change cancer

Doctors, researchers and audience gather at breakfast to learn about genetics, data and how working together will help beat cancer. The time is 8:15. Many have started to file in and shuffle to their seats while chatting and occasionally sipping their first morning coffee. As it starts to quiet down, the lights are dimmed, the […]

A Constant State of Liveliness

A driving force behind the collaboration between Ullern Upper Secondary School and Oslo Cancer Cluster is stepping down. This is her adventure. After fifteen great and productive years at Ullern Upper Secondary School, Esther Eriksen steps down from her position as vice principle in the upcoming month. Esther, who has been responsible for many various […]

Helping biotech companies through innovative IT solutions

The cluster-to-cluster project PERMIDES stimulates collaboration between biotech companies and IT companies. Its goal is to develop more innovative, personalized cancer treatments.   Oslo Cancer Cluster is currently involved in a big European collaboration through the cluster-to-cluster project PERMIDES. 24 May you can benefit from the project by joining the BIOMED INFORMATICS workshop in Oslo. This workshop […]

Vi vant Siva-prisen 2017!

Oslo Cancer Cluster Incubator stakk av med Siva-prisen for 2017 på årets Siva-konferanse i Trondheim. Slik beskriver Siva vinneren: Oslo Cancer Cluster Incubator er en pådriver til utvikling av diagnostikk og behandling av kreftpasienter ved hjelp av ny revolusjonerende teknologi. De jobber med å omsette kreftforskning til nye medisiner og behandlingsformer. Dette gir nytt håp for kreftpasienter og […]

Nominated as “Norway’s smartest industrial company”

Thermo Fisher Scientific is one of three finalists to win the award and title in Oslo this Tuesday. The technology which the biotech company is nominated for, is development of faster and cheaper DNA-sequencing. More than 70 companies were candidates for this year’s price, according to the Norwegian online tech magazine Teknisk Ukeblad.  Thermo Fisher Scientific is one […]

Ny rapport om helsenæringens verdi

En ny rapport om helsenæringens verdi er ute. Du kan laste ned rapporten her.     Oslo Cancer Cluster er del av et konsortium som ønsker en oversikt over helsenæringens tilstand i Norge. Helseindustrien er en ung næring i Norge. Derfor måles den ikke som andre næringer av Statistisk Sentralbyrå. Dette er grunnen til at konsortiet har […]